Abstract
Cancer, as the most serious threat to human health, poses millions of deaths in the world each year. In vitro cancer cell and biomarker detection is of great importance for early cancer diagnosis and therapy, which needs highly sensitive, selective and quantitative diagnosis platforms. Threedimensional paper-based electrochemical devices (3D-PEDs) have attracted considerable interest in biomedical fields in recent years based on their simplicity, low cost, portability, high sensitivity and selectivity. Recently, since 3D-PEDs can particularly provide in vitro 3D structures to mimic the native 3D cell microenvironment, they have been used to detect cancer cells and monitor their responses to anticancer drug treatment in terms of cancer cell concentration, cancer cell apoptosis and cancer biomarkers. This review discusses the recent development of 3D-PEDs and their applications in detection of cancer cells and anticancer drug screening.
Keywords: Paper-based electrochemical devices (PEDs), cancer cell detection, anticancer drug screening, cancer cell concentration, cancer cell apoptosis, cancer biomarker.
Current Pharmaceutical Biotechnology
Title:Recent Developments of Three-Dimensional Paper-Based Electrochemical Devices for Cancer Cell Detection and Anticancer Drug Screening
Volume: 17 Issue: 9
Author(s): Zedong Li, Jie Hu, Feng Xu and Fei Li
Affiliation:
Keywords: Paper-based electrochemical devices (PEDs), cancer cell detection, anticancer drug screening, cancer cell concentration, cancer cell apoptosis, cancer biomarker.
Abstract: Cancer, as the most serious threat to human health, poses millions of deaths in the world each year. In vitro cancer cell and biomarker detection is of great importance for early cancer diagnosis and therapy, which needs highly sensitive, selective and quantitative diagnosis platforms. Threedimensional paper-based electrochemical devices (3D-PEDs) have attracted considerable interest in biomedical fields in recent years based on their simplicity, low cost, portability, high sensitivity and selectivity. Recently, since 3D-PEDs can particularly provide in vitro 3D structures to mimic the native 3D cell microenvironment, they have been used to detect cancer cells and monitor their responses to anticancer drug treatment in terms of cancer cell concentration, cancer cell apoptosis and cancer biomarkers. This review discusses the recent development of 3D-PEDs and their applications in detection of cancer cells and anticancer drug screening.
Export Options
About this article
Cite this article as:
Li Zedong, Hu Jie, Xu Feng and Li Fei, Recent Developments of Three-Dimensional Paper-Based Electrochemical Devices for Cancer Cell Detection and Anticancer Drug Screening, Current Pharmaceutical Biotechnology 2016; 17 (9) . https://dx.doi.org/10.2174/1389201017666160519111702
DOI https://dx.doi.org/10.2174/1389201017666160519111702 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biodiversity and Chemodiversity: Future Perspectives in Bioprospecting
Current Drug Targets The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy Computational Methods for the Identification and Optimisation of High Quality Leads
Combinatorial Chemistry & High Throughput Screening Cardiovascular Tests: Use & Limits of Biochemical Markers - Therapeutic Measurements of ADMA Involved in Cardiovascular Disorders
Current Pharmaceutical Design Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
Current Drug Safety Fluid and Electrolyte Disorders in the Newborn: Sodium and Potassium
Current Pediatric Reviews Drug-Induced Pulmonary Hypertension in Newborns: A Review.
Current Vascular Pharmacology Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA
CNS & Neurological Disorders - Drug Targets Nutrient-By-Genotype Interactions and Personalized Diet: What Can We Learn From Drosophila and Evolutionary Biology?
Current Pharmacogenomics and Personalized Medicine Myogenic Tone as a Therapeutic Target for Ischemic Stroke
Current Vascular Pharmacology A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer
Current Cancer Drug Targets The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Mitophagy in Neurodegeneration: An Opportunity for Therapy?
Current Drug Targets Disruption of Circadian Rhythms and Sleep on Critical Illness and the Impact on Cardiovascular Events
Current Pharmaceutical Design Effect of SDF-1 α on Endogenous Mobilized and Transplanted Stem Cells in Regeneration after Myocardial Infarction
Current Pharmaceutical Design Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review
Current Drug Targets The Concept of Titration can be Transposed to Fluid Management. But does is Change the Volumes? Randomised Trial on Pleth Variability Index During Fast-Track Colonic Surgery
Current Clinical Pharmacology Effects of High Altitude Exposure on Physiology and Pharmacokinetics
Current Drug Metabolism Investigational Positive Inotropic Agents for Acute Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets The NMDA Receptor NR2B Subunit: A Valid Therapeutic Target for Multiple CNS Pathologies
Current Medicinal Chemistry